I want to
apply for IDAL’s incentives
know if I qualify for IDAL’s incentives
request IDAL’s support through the BSU
know if I qualify for the BSU Support
to know what are the BSU services
know what are the steps to open a business
know what are the licenses and permits needed to open a business
know more about Investment Opportunities in Lebanon
operate in Lebanon
export from Lebanon
access Global ICT Bids
About us
Investment Projects

Pharmaline

A Lebanese pharmaceutical company, Pharmaline is a member of Malia Group. Focusing on producing wide ranging branded generics at its expansive factory just north of Beirut; Pharmaline is also the trusted licensee of multinational brands including Abbott, Aegis,
GlaxoSmithKline, Merck Serono, Novartis, Phadisco, Pierre Fabre, Swisse, and Tripharma. Pharmaline has been awarded two ISO certificates: 9001 for quality management system and 14001 for environmental management system. It exports to countries throughout the Middle East, GCC, North Africa, Europe and Russia.

 

Sub-sector: Pharmaceuticals
Investment Size: USD 16.4 million
Jobs Created: 159
Type of Investment: Expansion
Nationality of Investor: Lebanese
Approval Date: 2012
Operation Date: 2014
Type of Incentive Scheme from IDAL: Package Deal Contract (PDC)
Website: www.pharmaline.com.lb

 

For more information, please download the Project Fiche.